Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: TransMart Foundation Board Members


The TranSmart foundation has added 13 new members to its board. Board members will serve one-year terms and meet quarterly.

Gold board members include Jamie Dananberg, the executive vice president of therapeutic areas at Takeda Pharmaceuticals; Brett Davis, general manager of ConvergeHealth by Deloitte and a principal at Deloitte Consulting; Matteo di Tomasso, the vice president of research business technology at Pfizer.

The list also includes Olivier Gien, global head for research and development health information technologies at Sanofi; Juergen Hammer, the global head for data science and center head of pharmaceutical research and early development informatics at Roche TCRC; and Jonathan Sheldon, global vice president of health sciences at Oracle.

The silver board members are Gilbert Omenn, a professor and director of the Center for Computational Medicine and Bioinformatics at the University of Michigan; Kenneth Pienta, a professor of urology at John Hopkins University hospital.

Bronze board members are James Burns, a professor in the department of microbiology and immunology at the Drexel University College of Medicine; and Lee Hood, the president of the Institute for Systems Biology.

Other board members are Hiroaki Kitano, the president of the Systems Biology Institute; Gerrit Meijer, the chair of the pathology department at VU University Medical Center in Amsterdam, and John Wilbanks, the chief commons officer of Sage Bionetworks.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.